Dana-Farber Research News 06.01.2026 - Takeaways - MDSpire

Dana-Farber Research News 06.01.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from May 1 - 15.

  • By

  • June 1, 2026

  • 38 min

Share

  • 1

    Dana-Farber's Research News highlights studies by faculty published from May 1-15, 2026.

  • 2

    Connexin-43 plays a critical role in hematopoietic regeneration and intercellular communication during stress hematopoiesis.

  • 3

    A study on Waldenström macroglobulinemia identified three evolutionary patterns of malignant B cells linked to treatment response to ibrutinib.

  • 4

    PSMD1, a proteasome subunit, is overexpressed in multiple myeloma and targeting it may improve therapeutic outcomes and overcome drug resistance.

  • 5

    Personalized cancer neoantigen vaccines aim to enhance tumor-specific immunity through targeting individual tumor mutations.

Original Source(s)

Dana-Farber Research News 06.01.2026

  • by

  • June 1, 2026

Related Content

Application of patient-derived organotypic tumor spheroids to guide combination immunotherapy for advanced HCC: a case report

Successful conversion therapy for presumed granulocyte colony-stimulating factor–producing hepatocellular carcinoma: a case report

Direct comparison of efficacy of combining ivermectin versus five first-line chemotherapy drugs with recombinant methioninase against colon-cancer cells